GlassScriptPhysician profile
Unique Catherine Robinson
NPI 1134502289
$24,313.19
in general payments reported to CMS, 2019-2025
66 companies · $5,737 in 2025
The $5,737 reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4,376 · 2022: $5,017 · 2023: $3,937 · 2024: $5,246 · 2025: $5,737.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Education: $122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14,797.33 |
| Education | $122.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,904.12 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $2,411.34 | 2021-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Biogen, INC. | $1,884.56 | 2021-2025 | Tysabri, Vumerity, Leqembi |
| Ucb, INC. | $1,841.72 | 2021-2025 | Briviact, Rystiggo, Nayzilam |
| Sk Life Science, INC. | $1,157.18 | 2021-2025 | |
| Emd Serono, INC. | $1,100.42 | 2021-2025 | Mavenclad |
| Pfizer INC. | $1,068.27 | 2023-2025 | |
| Argenx US, INC. | $883.17 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Acadia Pharmaceuticals INC | $679.16 | 2021-2025 | Nuplazid |
| Neurocrine Biosciences, INC. | $675.41 | 2021-2025 | Ingrezza, Ongentys |
| Neurelis, INC. | $571.89 | 2022-2025 | Valtoco |
| Sunovion Pharmaceuticals INC. | $561.60 | 2021-2022 | |
| Eisai INC. | $551.39 | 2021-2025 | |
| Lilly USA, LLC | $532.48 | 2021-2025 | Emgality, Amyvid, Kisunla |
| Lundbeck LLC | $530.32 | 2021-2025 | Vyepti, Rexulti |
Show all 66 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Unique Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.